Purvis Memorial Award
The Purvis Memorial Award recognizes an individual for significant strategy development and successful implementation within the Canadian chemical Industry.
SCI Innovation Award
Enabled by partnership
SCI's Innovation Award recognises and celebrates scientific innovation in industry that has been enabled as a direct result of collaborative partnerships. The award is for innovations across a variety of scientific business contexts and can include collaborative partnerships within a single organisation or stakeholders from different organisations, including partnerships with academia. The award is open to an individual or team working in a company of any size or country.Established 2023
Award Information
Eligibility Criteria
-
Background
- An individual or team working in a company of any size or country
- Applicants must be able to demonstrate collaboration with an individual, team, company or academic institution to achieve an innovative outcome to a business opportunity or challenge
- Global collaborative partnerships are welcome as well as those instances where collaboration has been with parties within the same country
- An industry that has a primary focus in products/processes requiring chemistry or chemistry-related science
- Innovations must be related to science across SCI key theme areas of Global Health, Climate Change and Sustainability
- Evidence of demonstrable, measurable outcomes as a result of the innovation will be requested as part of the application process
- Applications which can demonstrate a material impact for society will be favoured
Timetable
| Nominations open | 1 September 2024 |
| Nominations close | 10 January 2025 (extended deadline!) |
| Shortlist announced | April 2025 |
| Awards Dinner | May 2025 |
If you are interested in attending the SCI Awards Dinner 2025, please contact conferences@soci.org.
2024 Recipients
- WINNER: GSK and Medicines for Malaria Venture (MMV) - Identification of new antimalarials for the treatment of patients with uncomplicated malaria.
- 2nd place: ETH Zürich , Synple Chem AG and the University of Edinburgh - ‘vending machine for molecules – an automated synthesis console accelerating drug discovery’.
- 3rd place: AstraZeneca, the University of Manchester and Prozomix - jointly established the Centre for Biocatalytic Manufacture of New Modalities.
Read the report from the SCI Sustainability & Innovation Awards 2024
